local_hospital

Centre Hospitalier Eure-Seine

Address
Sis Boulevard Schwartzenberg, 27015 Évreux, France

Centre Hospitalier Eure-Seine

Centre Hospitalier Eure-Seine is a comprehensive clinical research facility conducting specialized investigations across multiple therapeutic domains. The center demonstrates particular expertise in comparative effectiveness research through non-inferiority trial designs, evaluating innovative treatment strategies against established standard-of-care protocols.

  • Pulmonary diseases and sarcoidosis treatment optimization with corticosteroid-sparing regimens
  • Severe allergic asthma management and biologic therapy optimization strategies
  • Thromboembolism prevention in orthopedic trauma and immobilization settings

The research center's clinical trial portfolio reflects a commitment to patient-centered care optimization, focusing on reducing treatment burden while maintaining therapeutic efficacy. Their investigations span from respiratory immunology to vascular medicine, with notable emphasis on treatment de-escalation strategies and alternative anticoagulation approaches in high-risk orthopedic populations. This multidisciplinary approach positions the center at the forefront of evidence-based medicine development.

Site Overview

assignment
5
connected trials
corporate_fare
4
sponsors
science
15
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
5
Total trials linked
Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 5 of 6 therapeutic areas and 12 of 15 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
4
Sponsors (total)
4
Active sponsors
3

Sponsor Network

Top 3 by active trials.

lock +2 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 978 other sites in France

description
Trial volume
5
Outperforms 63% of sites
public
Therapeutic diversity
6areas
Outperforms 76% of sites
groups
Sponsor diversity
4sponsors
Outperforms 62% of sites

Therapeutic Area Benchmark — France

Select a therapeutic area to compare against other sites in France.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: France

Market Share

Country: France

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Centre Hospitalier Eure-Seine

lock Showing 1 of 5 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Comparative Safety and Efficacy of Apixaban Versus Warfarin in Patients with End-Stage Renal Disease on Peritoneal Dialysis and Non-Valvular Atrial FibrillationCentre Hospitalier Universitaire De Caen NormandiePhase IIIRecruitingJan 2025

IMP list

lock Showing 1 of 15 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Prednisolone2Unknown2018-02-022024-10-28

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.